Ledger.Open graph →

SEC Form D · filed October 17, 2012

InCarda Therapeutics, Inc

Offering

$1.0M

Sold

$310K

Exemption

—

Industry

Pharmaceuticals

Location

PALO ALTO, X1

Type

—

People & firms on this filing (5)

Rangachari Narasimhan · Palo Alto, CAExec · Director Carlos A. Schuler · Palo Alto, CAExec · Director Rangachari Narasimhan · San Francisco, CAExec · Director Carlos A. Schuler · San Francisco, CAExec · Director John S. Patton · Palo Alto, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗